These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8406329)

  • 1. "Paradoxical" GH suppression by secretagogues in acromegaly?
    Ohashi S; Kaji H; Abe H; Chihara K
    Horm Metab Res; 1993 Jul; 25(7):393-4. PubMed ID: 8406329
    [No Abstract]   [Full Text] [Related]  

  • 2. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
    Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
    Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
    [No Abstract]   [Full Text] [Related]  

  • 3. [GH producing neoplasms].
    Demura R; Shizume K
    Nihon Rinsho; 1976 Oct; 34(10):2937-41. PubMed ID: 794529
    [No Abstract]   [Full Text] [Related]  

  • 4. Do "so-called" normal growth hormone concentrations (2-5 micrograms/l) indicate cure in acromegaly?
    Levitt NS; Ratanjee BD; Abrahamson MJ
    Horm Metab Res; 1995 Apr; 27(4):185-8. PubMed ID: 7750902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
    Candrina R
    Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
    Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevations in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly.
    Faglia G; Beck-Peccoz P; Travaglini P; Paracchi A; Spada A; Lewin A
    J Clin Endocrinol Metab; 1973 Aug; 37(2):338-40. PubMed ID: 4198260
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum gastrin levels in patients with acromegaly.
    Pawlikowski M; Owczarczyk I; Stepień H
    Horm Metab Res; 1981 Dec; 13(12):714-5. PubMed ID: 7319471
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical application of a sensitive immunoradiometric assay for human growth hormone].
    Shimatsu A; Hattori N; Tanoh T; Assadian H; Imura H
    Nihon Naibunpi Gakkai Zasshi; 1990 Jul; 66(7):715-25. PubMed ID: 2118864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP production by GHRH in GH-producing pituitary adenoma cells.
    Nakagawa K; Ishizuka T; Shimizu C; Matsuura Y; Wada N; Kijima H; Ito Y; Aida T; Abe H
    Horm Metab Res; 1992 Sep; 24(9):446-7. PubMed ID: 1330861
    [No Abstract]   [Full Text] [Related]  

  • 14. Invasive pituitary tumor producing acromegaly, extreme elevation of growth hormone, and abnormal growth in tissue culture.
    Crowell RM; Kjellberg RN; Kliman B; Kornblith PL
    Neurochirurgia (Stuttg); 1974 Jul; 17(4):129-35. PubMed ID: 4437693
    [No Abstract]   [Full Text] [Related]  

  • 15. [Growth hormone].
    Gava R; Plebani M; Beltrami GC; Grezzana L
    G Clin Med; 1990 Apr; 71(4):289-91, 294-6. PubMed ID: 2115015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Growth hormone releasing factor].
    Shizume K
    Nihon Rinsho; 1984 Jun; 42(6):1483-92. PubMed ID: 6434769
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex difference in the relation between sellar volume and basal and GH-releasing hormone stimulated GH in acromegaly.
    Smals AE; Pieters GF; Smals AG; Kloppenborg PW
    Acta Endocrinol (Copenh); 1988 Mar; 117(3):387-91. PubMed ID: 3132795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editorial: Hypothalmic neurohumors and pituitary tumors.
    Wilber JF
    J Chronic Dis; 1974 Sep; 27(7-8):325-7. PubMed ID: 4373490
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum growth hormone levels and size of pituitary tumour in untreated acromegaly.
    Wright AD; McLachlan MS; Doyle FH; Fraser TR
    Br Med J; 1969 Dec; 4(5683):582-4. PubMed ID: 5356545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suprasellar extension of tumor associated with increased cerebrospinal fluid activity of growth hormone.
    Hanson EJ; Miller RH; Randall RV
    Mayo Clin Proc; 1976 Jul; 51(7):412-6. PubMed ID: 933557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.